Skip to main content

Glucotrack, Inc. (GCTK)

Sector
Healthcare
Industry
Medical Instruments & Supplies
Last price
$0.30
As of

Kresmion compiles this page from GCTK's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Glucotrack, Inc. (GCTK): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-29.

As of . Source: SEC EDGAR filings for GCTK. Method and limitations.

COMPANY DOSSIER

See the full GCTK dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for GCTK on one page. Preview it with sample data, then open it live with a free account.

Preview the GCTK dossier

Active events for GCTK

FREE, NO ACCOUNT

Every event on GCTK, as it fires

New filings, 13F moves and cross asset events on GCTK land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

GCTK positions held by the managers we follow (2026Q2)

What the managers we follow bought and sold in Q2 2026

Manager / securityMarket value% of reported value
CITADEL ADVISORS LLC FundCUSIP 45824Q804 · 2026Q2$25K0.00%

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, GCTK

Going concern statement

GCTK's 10-Q filed Aug 14, 2026 states:

Based upon this review and our current financial condition, we have concluded that substantial doubt exists as to our ability to continue as a going concern.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on GCTK

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in GCTK on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on GCTK in the last 180 days.

Upstream: SEC EDGAR filings for GCTK

Kresmion, "Glucotrack, Inc. (GCTK) institutional holdings and SEC filings", data as of 2026-10-29, https://kresmion.com/research/GCTK. Upstream data: SEC EDGAR filings for GCTK.

Link to this data (HTML):

<a href="https://kresmion.com/research/GCTK">Glucotrack, Inc. (GCTK) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow GCTK on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to GCTK for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the GCTK dossier
Share

The GCTK intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.